• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Innova Captab Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 74713.0
  • ISIN : INE0DUT01020
887.70 -22 (-2.38%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    870.60

  • Today’s High

    912.60

  • Open

    912.60

  • Perv Close

    909.35

  • 52W Low

    586.25

  • 52W High

    1,260.00

Key Indicators

  • P/E(TTM)

    56.61

  • Mar.Cap (₹Cr.)

    5,079.86

  • Div & Yield %

    0.00

  • Book Value(₹)

    142.06

  • Debt-Equity Ratio

    -2.38

  • AGM Date

    01-Aug-2025

  • EPS

    15.65

  • P/E Ratio

    56.61

Financials Ratios

  • Debt-Equity Ratio

    0.38

  • Mar.Cap (₹Cr.)

    5,079.86

  • RONW (%)

    17.04

  • ROCE (%)

    18.76

Score Board

  • Equity (₹ in Cr.)

    57.22

  • BV (₹)

    142.10

  • Sales( ₹ in Cr.)

    958.06

  • NP (in Cr.)

    89.53

  • NP Var(%)

    29.0

  • Div%

    0.0

  • CPS (₹)

    18.60

  • EPS (₹)

    15.60

  • Traded Value (₹ in Lakhs)

    5,069.84

  • 52 Week High

    1,260.00

  • 52 Week Low

    586.25

  • Price BSE

    886.0

  • Price NSE

    888.00

  • Market Capital( in Cr.)

    5,069.84

  • P/C Ratio

    47.60

  • P/E Ratio

    56.60

  • Price Vs.BV

    15.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 958.06 864.93 858.67 785.46 410.66 373.32
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 958.06 864.93 858.67 785.46 410.66 373.32
Other Income 16.78 10.72 8.73 2.86 1.37 1.30
Stock Adjustments 11.34 1.35 1.48 -1.00 -1.64 7.76
Total Income 986.18 877.00 868.88 787.32 410.39 382.38
EXPENDITURE :            
Raw Materials 552.98 506.91 529.83 607.88 309.06 291.55
Power and Fuel Cost 15.07 11.58 9.42 7.90 5.48 5.54
Employee Cost 62.74 50.11 43.60 36.30 22.22 20.24
Other Manufacturing Expenses 189.58 163.40 157.91 11.67 5.25 4.30
Selling and Administration Expenses 17.52 19.77 17.66 16.63 9.57 7.61
Miscellaneous Expenses 9.22 6.54 3.21 5.57 2.96 0.91
Employee Benefit Expenses 62.74 50.11 43.60 36.30 22.22 20.24
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 847.11 758.31 761.63 685.95 354.54 330.15
Operating Profit 139.08 118.69 107.26 101.37 55.86 52.24
Interest 2.17 13.59 18.30 5.33 3.93 4.63
Gross Profit 136.91 105.10 88.96 96.04 51.93 47.61
Depreciation 17.02 11.40 10.66 7.40 5.59 10.08
Profit Before Tax 119.89 93.70 78.30 88.64 46.34 37.53
Current Tax 22.00 25.18 18.86 21.80 11.50 9.25
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 8.42 0.35 1.89 0.66 0.35 0.40
Reported Net Profit 89.47 68.16 57.55 66.18 34.50 27.89
Extraordinary Items -0.06 -1.38 1.66 -0.01 0.11 0.00
Adjusted Net Profit 89.53 69.54 55.89 66.19 34.39 27.89
Adjustment below Net Profit -0.22 0.28 -36.06 -0.17 -0.08 -0.02
P & L Balance brought forward 288.71 220.28 198.78 132.78 98.35 70.49
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 377.96 288.71 220.28 198.78 132.78 98.35
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 15.63 11.91 11.99 55.15 287.50 232.38
Earnings Per Share(Adj)-Unit Curr 15.63 11.91 - - - -
Book Value 142.06 126.47 55.90 175.69 1,206.84 919.62
Book Value(Adj)-Unit Curr 142.06 126.47 - - - -

Shareholding Pattern

  • Promoter Group

    50.90%

  • Public Share Holding

    49.10%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 29,127,371 50.90 29,127,371 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 29,127,371 50.90 29,127,371 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 131,145 0.23 131,145 15
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 928,484 1.62 928,484 1
Mutual Funds / UTI 6,074,838 10.62 6,074,838 9
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 4,252,547 7.43 4,252,547 8
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 11,387,014 19.90 11,387,014 33
2] Non Institution
Bodies Corporate 602,428 1.05 602,428 258
Clearing Members 5 0.00 5 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 127,187 0.22 127,187 571
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 125,764 0.22 125,764 967
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 12,793,565 22.36 12,793,565 14
Individuals holding nominal share capital up to Rs. 1 lakh 3,061,595 5.35 3,061,595 39,165
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 16,710,544 29.20 16,710,544 40,976
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 57,224,929 100.00 57,224,929 41,014

Company Background

Innova Captab LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Innova Captab Ltd
  • BSE Code : 74713.0
  • ISIN : INE0DUT01020

  • Incorporation Year

    2005

  • Registered Office

    601 Proxima Plot # 19
    Sector 30 A Vashi, Navi Mumbai,
    Maharashtra-400705

  • Telephone

    91-22-2564 2095

  • FAX

  • Chairman

    MANOJ KUMAR LOHARIWALA

  • Managing Director

    VINAY KUMAR LOHARIWALA

  • Company Secretary

    Neeharika Shukla

  • Auditor

    BSR & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Innova Captab Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Innova Captab 885.95 974.84 958.06 56.68 11.53
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10